Table 3.
Risks of GSTA1, GSTP1, GSTM1 Genetic and Allelic Polymorphisms With Regards to Developing PTDM
| 95% confidence interval | |||||
|---|---|---|---|---|---|
| Variable | N (%) | P | OR | Lower | Upper |
| GSTA1 | |||||
| CTa) | 16 (18.8) | 0.968 | 0.987 | 0.515 | 1.891 |
| TTa) | 2 (2.2) | 0.629 | 1.562 | 0.255 | 9.564 |
| CT/TTa) | 18 (21.2) | 0.929 | 1.029 | 0.551 | 1.919 |
| C | 150 (88.2) | 1 | |||
| T | 20 (11.8) | 0.822 | 1.067 | 0.608 | 1.871 |
| GSTP1 | |||||
| AGb) | 16 (18.8) | 0.061 | 0.55 | 0.295 | 1.029 |
| GGb) | 2 (2.4) | 0.744 | 1.353 | 0.221 | 8.293 |
| AG/GGb) | 18 (21.2) | 0.085 | 0.589 | 0.323 | 1.075 |
| A | 150 (88.2) | 1 | |||
| G | 20 (11.8) | 0.158 | 0.679 | 0.397 | 1.162 |
| GSTM1 | |||||
| Present | 28 (32.9) | 1 | |||
| Null | 57 (67.1) | 0.343 | 1.295 | 0.759 | 2.212 |
PTDM, posttransplantation diabetes mellitus; CI, confidence interval; GST, glutathione S‐transferase; OR, odds ratio.
a)
a)Means compared with GSTA1 CC genotype.
b)
b)Means compared with GSTP1 AA genotype.